Overview
AL-54478 Proof of Concept Study
Status:
Completed
Completed
Trial end date:
2011-10-01
2011-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alcon ResearchTreatments:
Latanoprost
Criteria
Inclusion Criteria:- Patients diagnosed with either OAG or OHT.
- Patients who are able to comply with the scheduled visits.
- Patients who have had a physical exam within 6 months of the Screening Visit.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Females of childbearing potential who meet any 1 of the following conditions: a)
Currently pregnant; b) Positive urine pregnancy test; c)Intend to become pregnant; d)
Breast feeding; e) Not using highly effective birth control measures.
- Patients with extreme narrow angle with complete or partial closure.
- Patients with a cup to disc ratio more than 0.8.
- Patients with a severe central visual field loss in either eye.
- Patients with chronic or recurrent inflammatory eye disease or acute ocular infection
or inflammation.
- Patients who have had ocular trauma within the past 6 months or have had intraocular
surgery within the past 6 months or have had ocular laser surgery within the past 3
months.
- Patients with best-correct visual acuity less than 20/80.
- Patients who have had ocular infection or inflammation within the past 3 months.
- Patients who have clinically relevant progressive retinal disease.
- Patients who have severe illness or conditions.
- Patients who have hypersensitivity to a prostaglandin analogu.e
- Patients who are unable to safely discontinue all IOP-lowering medications during
washout.
- Patients who are currently on therapy with another investigational agent within 30
days prior to the Screening Visit.
- Other protocol-defined exclusion criteria may apply.